Chromatography reagents market seen reaching $10.49 billion by 2030

The chromatography reagents market is projected to grow from $6.86 billion in 2025 to $10.49 billion by 2030, driven by pharmaceutical research, clinical diagnostics and tighter testing requirements across industries. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - Chromatography reagents are essential for separating and analyzing compounds in pharmaceutical, clinical, food, environmental and research testing. - Strong demand for precise and reliable analytical testing is expanding the market across multiple industries. - The market’s projected climb to $10.49 billion by 2030 points to continued spending on drug development, quality control and advanced lab methods.

What happened: - The chromatography reagents market is estimated at $6.86 billion in 2025 and is projected to reach $7.46 billion in 2026. - The market is forecast to grow at a 8.7% CAGR from 2025 to 2026 and at a 8.9% CAGR through 2030. - The Business Research Company said the market will reach $10.49 billion by 2030. - The report was published June 23, 2026.

The details: - Growth in 2025-2026 is linked to pharmaceutical research, clinical diagnostics, food and beverage testing, environmental monitoring and academic lab use. - Future growth is expected to be supported by higher investment in biopharmaceutical and precision medicine research. - Demand is also rising for highly sensitive analytical testing, advanced chromatography in forensic and clinical fields, and reagents that support quality control and regulatory compliance. - The report highlights growing demand for ultra-high purity reagents. - The report also points to wider use of advanced liquid chromatography in pharmaceuticals. - The report flags expanding applications in environmental and food safety testing. - Reproducibility and accuracy in complex sample analysis remain key market priorities. - A free sample of the report is available here. - The full report is available here.

Between the lines: - Rising pharmaceutical R&D spending is a major demand driver because chromatography reagents support screening, purity assessment and quality control during drug development. - The UK’s Department of Health and Social Care reported pharmaceutical R&D spending of $10.52 billion (£9 billion) in 2023, equal to 17% of total UK business R&D expenditure. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The regional outlook reflects broader research growth and industrial development outside the mature North American market.

What’s next: - Market momentum is expected to continue as labs adopt more advanced chromatography technologies and stricter testing standards. - Sustainable, high-efficiency reagents are likely to gain more attention as buyers look for better performance and lower waste. - The report’s 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspots infographics and updated trend analysis.

The bottom line: - Chromatography reagents are moving from steady growth to a stronger long-term expansion cycle, with drug discovery and precision testing doing most of the work.